Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA

Cisplatin (DDP) is a common therapeutic option for non‐small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. Therefore, identifying novel biomarkers to improve the diagnosis and treatment of NSCLC is important. Ubiquitin‐specific protease (USP14) is invol...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xinmin, Wu, Xianghua, Wang, Huijie, Lai, Songtao, Wang, Jialei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077057/
https://www.ncbi.nlm.nih.gov/pubmed/37035133
http://dx.doi.org/10.1002/mco2.237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077057/
https://www.ncbi.nlm.nih.gov/pubmed/37035133
http://dx.doi.org/10.1002/mco2.237

Ejemplares similares